There are two primary types of bone disorders observed in patients wit
h end-stage renal disease: a high-turnover osteodystrophy characterize
d by osteitis fibrosa, and a low-turnover osteodystrophy characterized
initially by osteomalacia and, more recently, by adynamic or aplastic
bone disease. This article reviews the clinical presentation, pathoge
nesis, and laboratory findings of patients with these two disorders. I
t discusses the important roles of phosphorus binding, vitamin D admin
istration, and correction of acidosis in prevention and treatment of b
one disease in patients with moderate renal insufficiency.